Balziva
- Generic Name: ethinyl estradiol and norethindrone tablets
- Brand Name: Balziva
- Drug Class: Contraceptives, Oral
Balziva (Ethinyl Estradiol and Norethindrone Tablets) side effects drug center
Balziva Side Effects Center
Balziva (norethindrone and ethinyl estradiol tablets) is an oral contraceptive indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception. Balziva is available in generic form. Common side effects of Balziva include:
- nausea,
- vomiting,
- abdominal cramps,
- bloating,
- breakthrough bleeding,
- spotting,
- changes in menstrual flow,
- missed menstrual periods,
- temporary infertility after discontinuation of treatment,
- swelling,
- freckles or darkening of facial skin,
- breast tenderness or enlargement,
- nipple discharge,
- change in weight,
- change in vaginal discharge,
- migraine,
- rash (allergic),
- depression,
- reduced tolerance to carbohydrates,
- vaginal yeast infection,
- and intolerance to contact lenses.
Cigarette smoking increases the risk of serious cardiovascular side effects from oral contraceptive use. Women who use oral contraceptives are strongly advised not to smoke.
The Balziva 28-pill pack has 21 “active” light peach pills (with hormones) to take for 3 weeks, followed by 1 week of reminder white pills (without hormones). Take one pill at the same time every day until the pack is empty. On the 28-day regimen, start the next pack the day after the last inactive tablet and not wait any days between packs. Balziva may interact with:
- rifampin,
- drugs used for epilepsy such as barbiturates and phenytoin,
- phenylbutazone,
- ampicillin,
- and tetracyclines.
Tell your doctor all medications and supplements you use. Balziva is not recommended for use during pregnancy. Small amounts of oral contraceptives such as Balziva pass into breast milk and may interfere with lactation by decreasing the quantity and quality of breast milk. Nursing mothers are advised to use other forms of contraception until the child is weaned. Consult your doctor before breastfeeding.
Our Balziva (norethindrone and ethinyl estradiol tablets) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
Balziva Consumer Information
Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Stop using this medicine and call your doctor at once if you have:
- signs of a stroke--sudden numbness or weakness (especially on one side of the body), sudden severe headache, slurred speech, problems with vision or balance;
- signs of a blood clot--sudden vision loss, stabbing chest pain, feeling short of breath, coughing up blood, pain or warmth in one or both legs;
- heart attack symptoms--chest pain or pressure, pain spreading to your jaw or shoulder, nausea, sweating;
- liver problems--loss of appetite, upper stomach pain, tiredness, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes);
- increased blood pressure--severe headache, blurred vision, pounding in your neck or ears;
- swelling in your hands, ankles, or feet;
- a change in the pattern or severity of migraine headaches;
- a breast lump; or
- symptoms of depression--sleep problems, weakness, tired feeling, mood changes.
Common side effects may include:
- nausea, vomiting;
- breast tenderness;
- breakthrough bleeding;
- headache; or
- problems with contact lenses.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Read the entire detailed patient monograph for Balziva (Ethinyl Estradiol and Norethindrone Tablets)
Balziva Professional Information
SIDE EFFECTS
An increased risk of the following serious adverse reactions has been associated with the use of oral contraceptives (see WARNINGS section):
- Thrombophlebitis
- Arterial thromboembolism
- Pulmonary embolism
- Myocardial infarction
- Cerebral hemorrhage
- Cerebral thrombosis
- Hypertension
- Gallbladder disease
- Hepatic adenomas or benign liver tumors
There is evidence of an association between the following conditions and the use of oral contraceptives, although additional confirmatory studies are needed:
- Mesenteric thrombosis
- Retinal thrombosis
The following adverse reactions have been reported in patients receiving oral contraceptives and are believed to be drug-related:
- Nausea
- Vomiting
- Gastrointestinal symptoms (such as abdominal cramps and bloating)
- Breakthrough bleeding
- Spotting
- Change in menstrual flow
- Amenorrhea
- Temporary infertility after discontinuation of treatment
- Edema
- Melasma which may persist
- Breast changes: tenderness, enlargement, and secretion
- Change in weight (increase or decrease)
- Change in cervical ectropion and secretion
- Possible diminution in lactation when given immediately postpartum
- Cholestatic jaundice
- Migraine
- Rash (allergic)
- Mental depression
- Reduced tolerance to carbohydrates
- Vaginal candidiasis
- Change in corneal curvature (steepening)
- Intolerance to contact lenses
The following adverse reactions have been reported in users of oral contraceptives, and the association has been neither confirmed nor refuted:
- Premenstrual syndrome
- Cataracts
- Changes in appetite
- Cystitis-like syndrome
- Headache
- Nervousness
- Dizziness
- Hirsutism
- Loss of scalp hair
- Erythema multiforme
- Erythema nodosum
- Hemorrhagic eruption
- Vaginitis
- Porphyria
- Impaired renal function
- Hemolytic uremic syndrome
- Budd-Chiari syndrome
- Acne
- Changes in libido
- Colitis
Read the entire FDA prescribing information for Balziva (Ethinyl Estradiol and Norethindrone Tablets)
&Copy; Balziva Patient Information is supplied by Cerner Multum, Inc. and Balziva Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.